Erythroleukemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Acute erythroid leukemia; acute Di Guglielmo syndrome; erythroleukemia | {{SK}} Acute erythroid leukemia; acute Di Guglielmo's syndrome; erythroleukemia; Erythroleukaemia; Erythraemic myelosis; Erythremic myelosis; Erythroleukaemia, FAB M6; M6 - Acute erythroleukaemia; M6 - Acute erythroleukemia | ||
==[[Erythroleukemia overview|Overview]]== | ==[[Erythroleukemia overview|Overview]]== | ||
==[[Erythroleukemia classification|Classification]]== | ==[[Erythroleukemia classification|Classification]]== | ||
Revision as of 18:11, 13 August 2015
Template:DiseaseDisorder infobox Template:Erythroleukemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Acute erythroid leukemia; acute Di Guglielmo's syndrome; erythroleukemia; Erythroleukaemia; Erythraemic myelosis; Erythremic myelosis; Erythroleukaemia, FAB M6; M6 - Acute erythroleukaemia; M6 - Acute erythroleukemia
Overview
Classification
Pathophysiology
Causes
Differentiating Erythroleukemia from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Diagnostic Studies
Treatment
Medical Therapy | Cost-Effectiveness of Therapy | Future or Investigational Therapies